Bio-Rad Laboratories

Yahoo Finance • 3 days ago

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Ameriprise Financial, Arista Networks, Arm Holdings, Lennar, Morgan Stanley, Rocket Lab, Tractor Supply, Wingstop, Wix.com and More

Quick Read The stock market started the first full trading week of the second quarter on a positive note. Investors and analysts will be anxiously awaiting first-quarter earnings results that will start in earnest next week with the large... Full story

Yahoo Finance • 9 days ago

Artisan Mid Cap Value Fund Sold Bio-Rad Laboratories (BIO) in Q4

Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Mid Cap Value Fund”.  A copy of the letter can be downloaded here. The Fund seeks to invest in undervalued companies with sol... Full story

Yahoo Finance • 9 days ago

Concerns Over Regulatory Challenges Affecting WaFd’s (WAFD) Mortgage Lending Business

Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Mid Cap Value Fund”.  A copy of the letter can be downloaded here. The Fund seeks to invest in undervalued companies with sol... Full story

Yahoo Finance • 9 days ago

Artisan Mid Cap Value Fund Sold LKQ Corp. (LKQ) Due to Low Valuation

Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Mid Cap Value Fund”.  A copy of the letter can be downloaded here. The Fund seeks to invest in undervalued companies with sol... Full story

Yahoo Finance • last month

[Latest] Global Malaria Diagnostics Market Size/Share Worth USD 1.45 Billion by 2035 at a 5.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Malaria Diagnostics Market size & share revenue was valued at approximately USD 0.90... Full story

Yahoo Finance • last month

Cancer Diagnostics Market Competitive Landscape Report 2025: Key Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033

Dublin, Feb. 24, 2026 (GLOBE NEWSWIRE) -- The "Cancer Diagnostics Market Key Players Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts" report has been added to Rese... Full story

Yahoo Finance • 2 months ago

Bio-Rad Laboratories (BIO) Returns To Profitability With Diagnostics Rebound – Is The Turnaround Durable?

In February 2026, Bio-Rad Laboratories reported fourth-quarter 2025 sales of US$693.2 million and net income of US$720 million, marking a return to profitability after a prior-year loss, alongside full-year 2025 sales of US$2.58 billion an... Full story

Yahoo Finance • 2 months ago

Stocks Settle Slightly Higher as Bond Yields Fall

The S&P 500 Index ($SPX) (SPY) on Friday closed up +0.05%, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +0.10%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.18%.  March E-mini S&P futures (ESH26) rose +0.03%, and March E... Full story

Yahoo Finance • 2 months ago

Stocks Edge Lower as AI Fears Linger

The S&P 500 Index ($SPX) (SPY) today is down -0.22%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.38%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.23%.  March E-mini S&P futures (ESH26) are down -0.20%, and March E-mini... Full story

Yahoo Finance • 2 months ago

Bio-Rad Laboratories (BIO) Shares Cross Below 200 DMA

In trading on Friday, shares of Bio-Rad Laboratories Inc (Symbol: BIO) crossed below their 200 day moving average of $281.97, changing hands as low as $251.00 per share. Bio-Rad Laboratories Inc shares are currently trading off about 11.7... Full story

Yahoo Finance • 4 months ago

Becton Dickinson, Bio-Rad, and Thermo Fisher Propel Safety and Automation in Blood Collection Tubes—New Market Report Highlights $7Billion Opportunity

Company Logo The blood collection tubes market presents opportunities through innovation in automated systems, advanced materials, and digital traceability to enhance workflow efficiency and compliance. Demand is driven by personalized me... Full story

Yahoo Finance • 4 months ago

Bio-Rad, Poly Medicure, and Sekisui Medical Power Rapid Expansion in the Venous Blood Collection Market Through 2032

Company Logo The venous blood collection market is poised for growth, driven by innovations in sampling technology and increasing demand due to chronic disease prevalence. Opportunities lie in automation, user safety, microfluidics, and r... Full story

Yahoo Finance • 4 months ago

In Vitro Diagnostic Quality Control Market: Strategy & Trends with Forecasts by Assay Type, by Place, by Product, by Manufacturer and by Country - Situation Analysis with Executive & Consultant Guides

Dublin, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The "In Vitro Diagnostic Quality Control Market: Strategy & Trends with Forecasts by Assay Type, by Place, by Product, by Manufacturer and by Country - Situation Analysis with Executive & Consult... Full story

Yahoo Finance • 4 months ago

Autoimmune Disease Diagnostics Market Competitive Landscape Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts

Company Logo The Autoimmune Disease Diagnostics industry is set for significant growth, projected to leap from US$ 5.70 billion in 2024 to US$ 10.63 billion by 2033, at a CAGR of 7.17%. Key growth drivers include a rising need for precise... Full story

Yahoo Finance • 5 months ago

HbA1c Testing Market Research Report 2025-2033, Profiles of Key Players - Danaher, F. Hoffmann-La Roche, Siemens, Abbott, Bio-Rad Laboratories, ARKRAY, Trinity Biotech, EKF Diagnostics

Company Logo The HbA1c testing market presents opportunities driven by rising Type 2 diabetes cases and advancements in testing technologies. Supportive healthcare initiatives and increased awareness enhance demand. Strategic insights, co... Full story

Yahoo Finance • 5 months ago

Here are the major earnings after the close Wednesday

Major earnings expected after the bell on Wednesday include: * Microsoft Corporation (MSFT [https://seekingalpha.com/symbol/MSFT]) * Alphabet (GOOG [https://seekingalpha.com/symbol/GOOG]) * Meta Platforms (META [https://seekingalpha... Full story

Yahoo Finance • 6 months ago

Bio-Rad (BIO) Surged as the Earnings Exceeded Expectations

Longleaf Partners, managed by Southeastern Asset Management, released its “Partners Fund” third-quarter 2025 investor letter. The letter can be downloaded here. The fund returned -0.33% in the third quarter, compared to the S&P 500’s 8.12... Full story

Yahoo Finance • 6 months ago

Ariel Focus Fund buys AJG, PBH and FI; exits ZIMV, CLB and BIO

* Ariel Focus Fund outperformed the Russell 1000 Value Index and S&P 500 Index by registering a growth of 20.76% in Q3 2025. While the Russell 1000 Value Index posted a gain of 5.33%, the S&P 500 Index registered a return of 8.12%. * I... Full story

Yahoo Finance • 6 months ago

Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays

Biodesix, Inc. Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer testing LOUISVILLE, Colo., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NYSE: BDSX), a leading diagnosti... Full story

Yahoo Finance • 6 months ago

GCC Liquid Biopsy Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Bio-Rad, Thermo Fisher Scientific, Johnson & Johnson, Guardant Health, QIAGEN, Sysmex

Company Logo The GCC Liquid Biopsy Market is projected to grow from US$ 98.24 million in 2024 to US$ 309.53 million by 2033, at a CAGR of 13.60%. This rapid growth is driven by rising cancer incidence, advances in genomics technology, inc... Full story